Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 10,986 shares at $25.07 ($275K) on 2024-02-12, disclosed to the SEC on 2024-02-14.
Scheduled sale ($275k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.07 | 5,493 | $138K | 50.0% |
| 2 | $25.07 | 5,493 | $138K | 50.0% |
| Total | $25.07 avg | 10,986 | $275K | 100% |
| Filing → |
| DYN | SELL | 2024-05-17 | $122K | — | Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |